Chimerix CEO Resigns, Names Replacement

(RTTNews) - Biopharmaceutical company Chimerix, Inc.(CMRX) Wednesday announced the appointment of Michelle Berrey as the company's Chief Executive Officer and President, succeeding Kenneth Moch, who is resigning to pursue other interests. The company said Michelle Berrey will also continue to serve as its Chief Medical Officer.

Before joining Chimerix, Berrey was Chief Medical Officer at Pharmasset, Inc., a company that focused on the development of nucleotide analogs for the treatment of hepatitis C, from 2007 until its acquisition by Gilead Sciences, Inc. in January 2012.